Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07185854Completed
Randomised trial (2 arms). Primary endpoint: Ocular Surface Disease Index at Week 9. Started Jan 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07185854.